Sign inJoin waitlistJoin the waitlist

Andrew Branagan

Hematology & Oncology · Massachusetts General Hospital

Credentials: · · · · · · ·

History

Yale New Haven Cancer Center
2012–2015
Dartmouth-Hitchcock Medical Center
2010–2012
University of Illinois Medical Center
2009–2010
Ben-Gurion University of Negev
2009

Research

Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia
Review · Seminars in Oncology · 2003 · 740 citations
Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's…
Review · Seminars in Oncology · 2003 · 251 citations
Polymorphisms in FcgammaRIIIA (CD16) receptor expression are associated with clinical response to rituximab in Waldenström's macroglobulinemia
Journal of Clinical Oncology · 2005 · 195 citations

Steven Treon
59 papers
Jorge Castillo
34 papers
Shayna Sarosiek
27 papers
NR
Noopur Raje
19 papers
AY
Andrew Yee
16 papers
Ken Anderson
16 papers
CF
Catherine Flynn
14 papers
Nikhil Munshi
13 papers
MM
Manit Munshi
11 papers
DC
Diana Cirstea
8 papers
Elizabeth O’Donnell
8 papers
Irene Ghobrial
8 papers · 2 as a fellow

Clinical trials

Teclistamab In Waldenstrom's Macroglobulinemia
Principal investigator · Not yet recruiting · Phase 2
Massachusetts General Hospital
2027–2029
Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM
Principal investigator · Recruiting · Phase 2
Massachusetts General Hospital
2024–2027
Covid-19 Vaccine Responsiveness in MM and Waldenstrom
Principal investigator · Completed
Massachusetts General Hospital
2021–2022
Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients
Principal investigator · Completed · Phase 2
Yale University
2015–2018